Chemours (NYSE:CC) had its price target raised by analysts at Truist Financial Corporation from $18.00 to $21.00. They now have a "buy" rating on the stock.
Chemours (NYSE:CC) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Chemours (NYSE:CC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan [Yahoo! Finance]
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan